Recruiting OBSERVATIONAL NCT05127148

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

Real-world Evidence of First-line Treatment With Pediatric-like Protocol for Adolescents and Young Adults Patients Diagnosed With Philadelphia-negative Acute Lymphoblastic Leukemia

Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda

Conditions Acute Lymphoblastic Leukemia, Adult

Interventions Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.

Updated 6 times since 2021 Last updated: Jan 8, 2024 Started: Mar 1, 2021 Primary completion: Mar 1, 2026 Completion: Dec 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Lymphoblastic Leukemia, Adult, this trial is actively recruiting participants. The trial is conducted by Grupo Argentino de Tratamiento de la Leucemia Aguda and has accumulated 6 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Sep 2024 — Sep 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2024 — Jul 2024 [monthly]

Recruiting
Feb 2023 — Feb 2024 [monthly]

Recruiting

▶ Show 1 earlier version

Dec 2021 — Feb 2023 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grupo Argentino de Tratamiento de la Leucemia Aguda

Data source: Grupo Argentino de Tratamiento de la Leucemia Aguda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• CABA, Argentina
• Paraná, Argentina